Henrik R. Jensen
Odense University Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Henrik R. Jensen.
Acta Oncologica | 2013
Stefan Starup Jeppesen; Tine Schytte; Henrik R. Jensen; Carsten Brink; Olfred Hansen
Abstract Introduction. Stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC) is now an accepted and patient friendly treatment, but still controversy exists about its comparability to conventional radiation therapy (RT). The purpose of this single-institutional report is to describe survival outcome for medically inoperable patients with early stage NSCLC treated with SBRT compared with high dose conventional RT. Material and methods. From August 2005 to June 2012, 100 medically inoperable patients were treated with SBRT at Odense University Hospital. The thoracic RT consisted of 3 fractions (F) of 15–22 Gy delivered in nine days. For comparison a group of 32 medically inoperable patients treated with conventional RT with 80 Gy/35–40 F (5 F/week) in the period of July 1998 to August 2011 were analyzed. All tumors had histological or cytological proven NSCLC T1-2N0M0. Results. The median overall survival was 36.1 months versus 24.4 months for SBRT and conventional RT, respectively (p = 0.015). Local failure-free survival rates at one year were in SBRT group 93% versus 89% in the conventional RT group and at five years 69% versus 66%, SBRT and conventional RT respectively (p = 0.99). On multivariate analysis, female gender and performance status of 0–1 and SBRT predicted improved prognosis. Conclusion. In a cohort of patients with NSCLC there was a significant difference in overall survival favoring SBRT. Performance status of 0–1, female gender and SBRT predicted improved prognosis. However, staging procedure, confirmation procedure of recurrence and technical improvements of radiation treatment is likely to influence outcomes. However, SBRT seems to be as efficient as conventional RT and is a more convenient treatment for the patients.
Acta Oncologica | 2008
Henrik R. Jensen; O. Hansen; Mogens Hjelm-Hansen; Carsten Brink
Purpose. The purpose of this study is to determine the inter- and intra-fractional respiration induced tumour movements as well as setup accuracy in a stereotactic body frame for stereotactic treatments of NSCLC patients. Patients and methods. From August 2005 to March 2008, 26 patients with NSCLC where given a stereotactic treatment. The patients were scanned with normal and uncoached respiration without use of abdominal compression. Each patient had CT-scans performed at four occasions throughout the treatment: As part of the CT-simulation and before the three radiotherapy treatments. At every occasion five individual CT-scans covering the tumour volume were obtained. In this way 20 scans where obtained from each patient. In each CT-scan the maximum positions of the tumour where located in all six directions, represented by the top, bottom, anterior, posterior, left and right part of the tumour. These coordinate constitute the data of this study. Results. The standard deviations of the respiration induced intra-fractional movements were: LR: 0.9 mm, AP: 1.6 mm and CC: 2.0 mm (1 SD). The inter-fractional movements were: LR: 1.1 mm, AP: 1.3 mm and CC: 1.7 mm (1 SD). Finally the set up accuracies in the body frame were LR: 1.5 mm, AP: 1.1 mm and CC: 1.7 mm (1 SD). Discussion and conclusions. Consecutive CT scans can be used to evaluate the respiration induced tumour movement. For patients immobilized in a stereotactic body frame, large movements of the tumour are rarely seen within the lung. With consecutive scans, using a conventional CT-scanner, it is possible to select those patients in whom the tumour movement is large. Application of 4D CT and Cone beam verification is strongly encouraged to minimize the requested treatment margin.
Acta Oncologica | 2010
Jonas Westberg; Henrik R. Jensen; Anders Bertelsen; Carsten Brink
Abstract Background. In modern radiotherapy accelerators are equipped with 3D cone-beam CT (CBCT) which is used to verify patient position before treatment. The verification is based on an image registration between the CBCT acquired just before treatment and the CT scan made for the treatment planning. The purpose of this study is to minimise the scan time of the CBCT without compromising the accuracy of the image registration in IGRT. Material and methods. Fast scans were simulated by reducing the number of acquired projection images, i.e. new reconstructions based on a subset of the original projections were made. The deviation between the registrations of these new reconstructions and the original registration was measured as function of the amount of reduction. Results and Discussion. Twenty nine head and neck (H&N) and 11 stereotactic lung patients were included in the study. The mean of the registration deviation did not differ significantly from zero independently of the number of projections included in the reconstruction. Except for the smallest subset of reconstructions (10% and 25% of the original projection for the lung and H&N patients, respectively) the standard deviation of the registration differences was constant. The standard deviations were approximately 0.1 mm and 0.2 mm for the H&N and lung group, respectively. Based on these results an in-house developed solution, able to reduce the Cone-Beam CT scan time, has been implemented clinically.
Acta Oncologica | 2009
Morten Nielsen; Anders Bertelsen; Jonas Westberg; Henrik R. Jensen; Carsten Brink
Purpose. To quantify by means of cone beam CT the random and systematic uncertainty involved in radiotherapy, and to determine if this information can be used for e.g. technical quality assurance, evaluation of patient immobilization and determination of margins for the treatment planning. Patients and methods. Eighty four cancer patients have been cone beam CT scanned at treatment sessions 1, 2, 3, 10 and 20. Translational and rotational errors are analyzed. Results and conclusions. For the first three treatment sessions the mean translational error in the AP direction is 1 mm; this indicates a small error in the calibration of coronal isocentric laser. The observed SD of the systematic error in each direction is 1 mm if a correction is made after the third fraction with an action limit of 4 mm. The SD of the random errors of the patient group is approximately 1 mm in each direction. The rotational errors have a vanishing mean and a systematic error of 0.5–1.2 degrees and a random error of 0.4–0.7 degrees. The uncertainties from the first three treatment sessions (disregarding rotations) lead to a margin of 4 mm from ITV to PTV for Head-and-Neck patients (all directions) and Thorax patients (AP and lateral directions). In the CC direction, the margin has to be 5 mm for the Thorax patients. The total uncertainty on the patient position grows during the treatment course, especially in the CC direction for patients receiving thoracical irradiation. This may stem from problems in the immobilization of these patients. Consequently, it may be necessary to increase the margins in the CC direction. Once the CBCT scans have been made, the information is available for off-line analysis without any extra workload. Thus, the CBCT data can supplement scheduled QA checks.
Acta Oncologica | 2009
Anders Bertelsen; Morten Nielsen; Jonas Westberg; Henrik R. Jensen; Carsten Brink
Background. During external radiotherapy daily or even weekly image verification of the patient position might be problematic due to the resulting workload. Therefore it has been customary to perform image verification only at the first treatment fraction. In this study it is investigated whether the patient position uncertainty at the initial three treatment fractions is representative for the uncertainty throughout the treatment course. Methods. Seventy seven patients were treated using Elekta Synergy accelerators. The patients were immobilized during treatment by use of a customized VacFix™ bag and a mask of AquaPlast®. Cone beam CT (CBCT) scans were performed at fractions 1, 2, and 3 and at the 10th and 20th treatment fractions. Displacements in patient position, translational and rotational, have been measured by an image registration of the CBCT and the planning CT scan. The displacements data are evaluated retrospectively and the effect of Action Level (AL) image verification protocols based on sessions 1, 2, 3 are simulated. The resulting overall patient position uncertainties of the different protocols are evaluated at the 10th and 20th fractions. Results and conclusions. The differences between the addressed protocols are shown to be very small compared to the overall increase in patient position uncertainty during the treatment course. Thus the main problem in achieving the smallest possible uncertainty for the overall treatment is not the selection of ‘the best’ image verification protocol for the initial three fractions. The main challenge is that the overall patient position uncertainty increases during the treatment course. Information about the patient position during the first three fractions is therefore not representative for the overall patient position. For these types of patients and immobilization equipment it would consequently be an advantage to reduce the number of image verification sessions during the initial fractions and then compensate with additional imaging sessions during the remaining treatment course.
Acta Oncologica | 2017
Rasmus Lübeck Christiansen; Henrik R. Jensen; Carsten Brink
Abstract Background: Current state of the art radiotherapy planning of prostate cancer utilises magnetic resonance (MR) for soft tissue delineation and computed tomography (CT) to provide an electron density map for dose calculation. This dual scan workflow is prone to setup and registration error. This study evaluates the feasibility of an MR-only workflow and the validity of dose calculation from an MR derived pseudo CT. Material and methods: Thirty prostate cancer patients were CT and MR scanned. Clinical treatment plans were generated on CT using a single 18 MV arc volumetric modulated arc therapy (VMAT) with a prescription of 78 Gy/39 fractions. Dose was recalculated on pseudo CT and assuming uniform water density. Pseudo CT and uniform density based dose calculations were compared to CT dose calculations by gamma analysis. One patient was treated with a plan based solely on MR and pseudo CT including daily image guided radiotherapy (IGRT) performed by manual match of implanted gold markers. Results: A pseudo CT was generated for 29 of the 30 patients. Median gamma pass rates for 1%/1 mm passing criteria for dose calculated on pseudo CT when compared to CT were 100% for most evaluated structures. Dose calculated on uniform density also yielded high median pass rates, but with a higher occurrence of pass rates below 95%. Cases of pass rate below 95% on pseudo CT proved to originate from the presence of rectal air on CT, not represented by the pseudo CT. Treatment based on MR alone was successfully delivered to one patient, including manually performed daily IGRT. Conclusions: Median gamma pass rates were high for pseudo CT and proved superior to uniform density. Local differences in dose calculations were concluded not to have clinical relevance. Feasibility of the MR-only workflow was demonstrated through successful delivery of a treatment course planned based on MR alone.
Journal of Clinical Oncology | 2011
Stefan S. Jeppesen; Tine Schytte; Henrik R. Jensen; Carsten Brink; Olfred Hansen
Radiotherapy and Oncology | 2016
Rasmus Lübeck Christiansen; Henrik R. Jensen; D. Georg; Carsten Brink
International Journal of Radiation Oncology Biology Physics | 2016
Rasmus Lübeck Christiansen; Henrik R. Jensen; Carsten Brink
Archive | 2011
S. Agergaard; Henrik R. Jensen; Carsten Brink